TREZONOM Trademark

Trademark Overview


On Wednesday, September 19, 2012, a trademark application was filed for TREZONOM with the United States Patent and Trademark Office. The USPTO has given the TREZONOM trademark a serial number of 85732632. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 19, 2018. This trademark is owned by Novartis AG. The TREZONOM trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalm...
trezonom

General Information


Serial Number85732632
Word MarkTREZONOM
Filing DateWednesday, September 19, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 19, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services(Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives (Based on 44(e) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 22, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, March 19, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 19, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, August 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2017EXTENSION 5 GRANTED
Saturday, July 29, 2017EXTENSION 5 FILED
Saturday, July 29, 2017TEAS EXTENSION RECEIVED
Saturday, February 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2017EXTENSION 4 GRANTED
Thursday, February 9, 2017EXTENSION 4 FILED
Thursday, February 9, 2017TEAS EXTENSION RECEIVED
Saturday, August 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2016EXTENSION 3 GRANTED
Sunday, August 7, 2016EXTENSION 3 FILED
Sunday, August 7, 2016TEAS EXTENSION RECEIVED
Saturday, March 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2016EXTENSION 2 GRANTED
Tuesday, February 9, 2016EXTENSION 2 FILED
Thursday, March 10, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 9, 2016TEAS EXTENSION RECEIVED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2015EXTENSION 1 GRANTED
Tuesday, August 4, 2015EXTENSION 1 FILED
Tuesday, August 4, 2015TEAS EXTENSION RECEIVED
Tuesday, February 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 12, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 27, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, April 14, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, September 30, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 19, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 19, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, March 19, 2013SUSPENSION LETTER WRITTEN
Thursday, March 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 6, 2013ASSIGNED TO LIE
Monday, March 4, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 5, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 5, 2013NON-FINAL ACTION E-MAILED
Tuesday, February 5, 2013NON-FINAL ACTION WRITTEN
Thursday, January 31, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 30, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 17, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 17, 2013LETTER OF SUSPENSION E-MAILED
Thursday, January 17, 2013SUSPENSION LETTER WRITTEN
Wednesday, January 16, 2013ASSIGNED TO EXAMINER
Saturday, September 22, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 22, 2012NEW APPLICATION ENTERED IN TRAM